| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |